SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-058454
Filing Date
2021-11-12
Accepted
2021-11-12 09:10:39
Documents
56
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0921_relmadatherap.htm   iXBRL 10-Q 610581
2 CERTIFICATION f10q0921ex31-1_relmadathera.htm EX-31.1 16142
3 CERTIFICATION f10q0921ex31-2_relmadathera.htm EX-31.2 15592
4 CERTIFICATION f10q0921ex32-1_relmadathera.htm EX-32.1 7106
5 CERTIFICATION f10q0921ex32-2_relmadathera.htm EX-32.2 6708
  Complete submission text file 0001213900-21-058454.txt   3493705

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE rlmd-20210930.xsd EX-101.SCH 44912
7 XBRL CALCULATION FILE rlmd-20210930_cal.xml EX-101.CAL 23832
8 XBRL DEFINITION FILE rlmd-20210930_def.xml EX-101.DEF 186935
9 XBRL LABEL FILE rlmd-20210930_lab.xml EX-101.LAB 391721
10 XBRL PRESENTATION FILE rlmd-20210930_pre.xml EX-101.PRE 197350
11 EXTRACTED XBRL INSTANCE DOCUMENT f10q0921_relmadatherap_htm.xml XML 313851
Mailing Address 2222 PONCE DE LEON BLVD. 3RD FLOOR CORAL GABLES FL 33134
Business Address 2222 PONCE DE LEON BLVD. 3RD FLOOR CORAL GABLES FL 33134 646 876 3459
RELMADA THERAPEUTICS, INC. (Filer) CIK: 0001553643 (see all company filings)

IRS No.: 455401931 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39082 | Film No.: 211400321
SIC: 2834 Pharmaceutical Preparations